Mannose-6-Phosphate/Insulin-Like Growth Factor-II Receptors may Represent a Target for the Selective Delivery of Mycophenolic Acid to Fibrogenic Cells
- 1.6k Downloads
The insulin-like growth factor axis plays an important role in fibrogenesis. However, little is known about mannose-6-phosphate/Insulin-like growth factor-II receptor (M6P/IGF-IIR) expression during fibrosis. When expressed preferentially on fibrogenic cells, this receptor may be used to selectively deliver drugs to these cells. We investigated M6P/IGF-IIR expression in livers of bile duct-ligated (BDL) rats and in renal vascular walls of renin transgenic TGR(mRen2)27 rats. Both models are characterized by fibrogenic processes. Furthermore, we studied whether drug delivery via M6P/IGF-II-receptor-mediated uptake is possible in fibroblasts.
Materials and Methods/Results
M6P/IGF-IIR mRNA expression was investigated 3, 7 and 10 days after BDL. At all time-points hepatic M6P/IGF-IIR expression was significantly increased compared to healthy controls. Moreover, immunohistochemical staining revealed that α-sma-positive cells were M6P/IGF-IIR-positive. In kidneys of TGR(mRen2)27 rats, the number of M6P/IGF-IIR-positive arteries per microscopic field was increased 5.5 fold over healthy controls. To examine whether M6P/IGF-IIRs could be used as a port of entry for drugs, we coupled mycophenolic acid (MPA) to mannose-6-phosphate-modified human serum albumin (M6PHSA). M6PHSA-MPA inhibited 3T3-fibroblast proliferation dose-dependently, which was reversed by co-incubation with excess M6PHSA, but not by HSA.
M6P/IGF-IIRs are expressed by fibrogenic cells and may be used for receptor-mediated intracellular delivery of the antifibrogenic drug MPA.
Key wordsdrug targeting liver fibrosis mycophenolic acid TGR(mRen2)27 rats vascular lesions
hepatic stellate cell
mannose-6-phosphate-modified human serum albumin
mannose-6-phosphate/insulin-like growth factor-II receptor
phosphate buffered saline
TGR(mRen2)27 transgenic rats
α-smooth muscle actin
This study was financially supported by the Dutch Foundation for Technical Sciences (STW), grant no GFA.5460. Prof. D.K.F. Meijer is gratefully acknowledged for valuable scientific discussion and review of the manuscript.
- 5.D. P. Faxon, V. Fuster, P. Libby, J. A. Beckman, W. R. Hiatt, R. W. Thompson, J. N. Topper, B. H. Annex, J. H. Rundback, R. P. Fabunmi, R. M. Robertson, and J. Loscalzo. Atherosclerotic vascular disease conference: Writing Group III: pathophysiology. Circulation 109:2617–2625 (2004).PubMedCrossRefGoogle Scholar
- 10.H. Shimizu, M. Takahashi, S. Takeda, S. Inoue, J. Fujishiro, Y. Hakamata, T. Kaneko, T. Murakami, K. Takeuchi, I. Takeyoshi, Y. Morishita, and E. Kobayashi. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation 77:1661–1667 (2004).PubMedCrossRefGoogle Scholar
- 17.P. J. de Bleser, P. Jannes, S. C. van Buul-Offers, C. M. Hoogerbrugge, C. F. van Schravendijk, T. Niki, V. Rogiers, J. L. van den Brande, E. Wisse, and A. Geerts. Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology 21:1429–1437 (1995).PubMedGoogle Scholar
- 20.L. Beljaars, G. Molema, B. Weert, H. Bonnema, P. Olinga, G. M. Groothuis, D. K. Meijer, and K. Poelstra. Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology 29:1486–1493 (1999).PubMedCrossRefGoogle Scholar
- 29.G. Pugliese, F. Pricci, N. Locuratolo, G. Romeo, G. Romano, S. Giannini, B. Cresci, G. Galli, C. M. Rotella, and U. Di Mario. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production. Diabetologia 39:775–784 (1996).PubMedCrossRefGoogle Scholar
- 34.M. M. van den Eijnden, J. J. Saris, R. J. de Bruin, E. de Wit, W. Sluiter, T. L. Reudelhuber, M. A. Schalekamp, F. H. Derkx, and A. H. Danser. Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors. Arterioscler. Thromb. Vasc. Biol. 21:911–916 (2001).PubMedGoogle Scholar
- 37.H. Tedesco-Silva, M. C. Bastien, L. Choi, C. Felipe, J. Campestrini, F. Picard, and R. Schmouder. Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil. Transplant. Proc. 37:852–855 (2005).PubMedCrossRefGoogle Scholar
- 39.L. Beljaars, G. Molema, D. Schuppan, A. Geerts, P. J. de Bleser, B. Weert, D. K. Meijer, and K. Poelstra. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor. J. Biol. Chem. 275:12743–12751 (2000).PubMedCrossRefGoogle Scholar